Archive

Home > 

07 May

Posted at 11:12h in

Company name & Address: registration number Batch number(s) Expiry date Pack size First release date Re-call Classification Recall date Dr Reddy’s Laboratories (Pty) Ltd Block C, Woodmead North Office Park, 54 Maxwell Drive, Woodmead, Sandton   56/8.2/0106   T2504569   August 2027   60’s   21 January 2026   Class II Type B   04 May 2026     Brief description of the problem (reason for recall) This recall is initiated due...

07 May

Posted at 11:11h in

Company name & Address: registration number Batch number(s) Expiry date Pack size First release date Re-call Classification Recall date Eisai Pharmaceuticals Africa (Pty) Ltd 2nd Floor, Golden Oak House, Ballyoaks Office Park, 35 Ballyclare Drive, Bryanston   48/26/0047   148482   May 2028   1 vial   06 December 2024   Class II Type C   04 May 2026   Brief description of the problem (reason for recall) This recall is initiated...

07 May

Posted at 11:09h in

Company name & Address: registration number Batch number(s) Expiry date Pack size First release date Re-call Classification Recall date Bioweb (Pty) Ltd Ridgeview Office Park 248 Kent Avenue Unit 10 Randburg 2194   N/A   6253410   02 June 2028   2ml   Not available   Class III Type C   04 May 2026   Brief description of the problem (reason for recall) This recall has been initiated following an internal technical investigation, which determined...

04 May

Posted at 16:15h in

Company name & Address: registration number Batch number(s) Expiry date Pack size First release date Re-call Classification Recall date Austell Pharmaceuticals (Pty) Ltd 1 Sherborne Road, Parktown, Johannesburg   38/20.1.1/0011   AEW014001   31 January 2028   10 Tablets   05 July 2024   Class III Type C   24 April 2026 Brief description of the problem (reason for recall) This recall is initiated due to: The inclusion of an...

04 May

Posted at 16:11h in

The Regulatory Compliance Unit of the South African Health Products Regulatory Authority (SAHPRA) is mandated to ensure that the marketing and promotion of medicines, scheduled substances, medical devices, and in vitro diagnostic medical devices (IVDs), for both human and veterinary use, comply with the Medicines...

30 Apr

Posted at 10:03h in

Company name & Address: registration number Batch number(s) Expiry date Pack size First release date Re-call Classification Recall date Cipla Medpro (Pty) Ltd Building 2 Junxion Park 10 Elephant Lane Century City South Africa 7441   A40/21.2/0149   4GC0350 GC30719   February 2027 July 2026   30s   06 August 2024 30 November 2023   Class II Type B   20.April.2026   Brief description of the problem (reason for recall) This recall is initiated because of a dissolution failure...

30 Apr

Posted at 10:01h in

Company name & Address: Product strength registration number Batch number(s) Expiry date Pack size First release date Re-call Classification Recall date Ge Healthcare (Pty) Ltd Office Suite BOG Ground Floor Level, Building B Stoneridge Office Park 8 Greenstone Place, Greenstone Hill Johannesburg, Gauteng South Africa, 1609 Visipaque 320 mg/ml 100 ml   31/28/0177   17244629   August 2028     100 ml   12 December 2025     Class II Type B   20.April.2026   Brief description of the...

30 Apr

Posted at 10:00h in

Company name & Address: Product strength registration number Batch number(s) Expiry date Pack size First release date Re-call Classification Recall date Ge Healthcare (Pty) Ltd Office Suite BOG Ground Floor Level, Building B Stoneridge Office Park 8 Greenstone Place, Greenstone Hill Johannesburg, Gauteng South Africa, 1609 Omnipaque 300 mg/100 ml   X/28/80   17262906 17314099   August 2028 August 2028   100 ml   12 December 2025 12 December 2025   Class II Type B   20.April.2026 Omnipaque 350...

28 Apr

Posted at 17:03h in

Company name & Address: registration number Batch number(s) Expiry date Pack size First release date Re-call Classification Recall date Pharmaco Distribution 91 Protea Road Chislehurston Sandton 2196     N/A       251485     23 October 2027     1 sterile unit per pack     22 December 2025     Class I Type B     17.April.2026 This recall is being conducted due to a manufacturing defect that may result in breakage of the handle...

27 Apr

Posted at 16:38h in

Brief description of the problem (reason for recall) The recall follows the identification of potential foreign material contamination during an Adcock Ingram Clayville factory inspection conducted by the SAHPRA Inspectorate.   Advise for health professionals and distributors: Retail pharmacies, wholesalers, distribution centres are requested to refrain from selling any...